The authors examined whether reduced levels of endogenous progesterone are associated with the disease in FTD patients and whether exogenous progesterone can modulate the levels of the two major proteins associated with FTD pathology, namely Tau and TDP-43 (encoded by the TARDBP gene) in a cellular model. This evidence concerns the gene MAPT and frontotemporal dementia.